Parents see own health spiral as their kids’ mental illnesses worsen

As the FDA ex­plores how to re­form its ad­vi­so­ry com­mit­tees in ways to en­sure the agency re­ceives more time­ly and sound ad­vice — a process

Nek­tar Ther­a­peu­tics said its for­mer part­ner Eli Lil­ly had pre­sent­ed “er­ro­neous da­ta” for its atopic der­mati­tis drug be­fore break­ing off a $400 mil­lion al­liance. Where­as

The FDA is­sued a warn­ing let­ter to NeilMed Phar­ma­ceu­ti­cals, an over-the-counter man­u­fac­tur­er of nasal and ear care prod­ucts, cit­ing is­sues with clean­ing and in­gre­di­ent test­ing